Financhill
Back

Cannara Biotech, Inc. Stock Predictions

Cannara Biotech, Inc. Stock Forecast

  • Is Cannara Biotech, Inc. Stock Undervalued?
    The current Cannara Biotech, Inc. [LOVE.V] share price is $1.69. The Score for LOVE.V is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • LOVE.V is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Cannara Biotech, Inc. Stock Go Up Next Year?

Data Unavailable

Cannara Biotech, Inc. Stock Rating

Data Unavailable

Cannara Biotech, Inc. Stock Price History

Is LOVE.V stock going to rise?

  • The current trend is relatively stagnant and LOVE.V is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
TSXV
Country:
Canada
Industry:
Personal Care Products
Sector:
Consumer Staples
Type:
stock
Website:
cannara.ca

52-Week Data

52-Week High:
1.99
52-Week Low:
0.69

Prediction Charts

Market Cap:
160.5M
Price in USD:
1.69
Volume:
28.4K
Beta:
1.03

Technical Analysis

SMA50:
1.70
SMA100:
1.75
SMA200:
1.58
52-Wk Change:
116.67%

Stock Predictions

  • Is Cannara Biotech, Inc. stock public?
    Yes, Cannara Biotech, Inc. is a publicly traded company.
  • What is the Cannara Biotech, Inc. stock quote today?
    The Cannara Biotech, Inc. stock price is 1.69 USD today.
  • How to buy Cannara Biotech, Inc. stock online?
    You can buy Cannara Biotech, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-5 1.66 1.69 1.71 1.66
Dec-8 1.71 1.71 1.76 1.65
Dec-9 1.68 1.69 1.71 1.65
Dec-10 1.70 1.70 1.72 1.69
Dec-11 1.71 1.75 1.76 1.71
Dec-12 1.78 1.80 1.80 1.77
Dec-15 1.80 1.80 1.80 1.72
Dec-16 1.78 1.79 1.80 1.78
Dec-17 1.80 1.79 1.80 1.77
Dec-18 1.80 1.73 1.80 1.73
Dec-19 1.75 1.76 1.79 1.73
Dec-22 1.77 1.71 1.79 1.71
Dec-24 1.70 1.68 1.70 1.68
Dec-29 1.69 1.69 1.70 1.66

Cannara Biotech, Inc. Earnings

Data Unavailable

Cannara Biotech, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.03 per share.

* Cannara Biotech, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.